لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Jerry Radich, Steven Coutre, Hanna Jean Khoury, Lydia Roy, Carlo Gambacorti-Passerini, Emmanuel Raffoux, Mauricette Michallet, S. Corm, Thomas Ernst, Chao Zhu, Ellen K. Ritchie, J. M.A. Van Tornout, Jorge E. Cortes, Giovanna Rege-Cambrin, Moshe Talpaz, Dahye Kim, Giovanni Martinelli, Andreas Hochhaus, Jih-Luh Tang, Tim H. Brümmendorf, Nelson Hamerschlak

المساهمون: Cortes J, Kim DW, Raffoux E, Martinelli G, Ritchie E, Roy L, Coutre S, Corm S, Hamerschlak N, Tang JL, Hochhaus A, Khoury HJ, Brümmendorf TH, Michallet M, Rege-Cambrin G, Gambacorti-Passerini C, Radich JP, Ernst T, Zhu C, Van Tornout JM, Talpaz M., Cortes, J, Kim, D, Raffoux, E, Martinelli, G, Ritchie, E, Roy, L, Coutre, S, Corm, S, Hamerschlak, N, Tang, J, Hochhaus, A, Khoury, H, Brümmendorf, T, Michallet, M, Rege Cambrin, G, GAMBACORTI PASSERINI, C, Radich, J, Ernst, T, Zhu, C, Van Tornout, J, Talpaz, M

مصطلحات موضوعية: Male, Cancer Research, Myeloid, Administration, Oral, Gastroenterology, Piperazines, Blast Crisi, Antineoplastic Agent, hemic and lymphatic diseases, Aged, 80 and over, education.field_of_study, DASATINIB, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, Hematology, Middle Aged, Combined Modality Therapy, Dasatinib, Treatment Outcome, medicine.anatomical_structure, Oncology, Tolerability, Benzamides, Imatinib Mesylate, Female, Human, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Population, Protein Kinase Inhibitor, Antineoplastic Agents, Genes, abl, IMATINIB, Disease-Free Survival, Young Adult, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, medicine, Humans, MYELOID LEUKEMIA, education, Piperazine, Protein Kinase Inhibitors, neoplasms, Aged, business.industry, medicine.disease, Surgery, Thiazoles, Pyrimidines, Imatinib mesylate, Pyrimidine, Drug Resistance, Neoplasm, Thiazole, Blast Crisis, business, Febrile neutropenia, Chronic myelogenous leukemia

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1aaef84dda039a4c2e7325052eeea58
http://hdl.handle.net/11585/69999

المؤلفون: Hanna GJ; Dana-Farber Cancer Institute, Center for Salivary and Rare Head and Neck Cancers, Boston, Massachusetts., Ahn MJ; Samsung Medical Center, Department of Hematology and Oncology, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Muzaffar J; Moffitt Cancer Center, Department of Head and Neck-Endocrine Oncology, Tampa, Florida., Keam B; Seoul National University Hospital, College of Medicine, Seoul, Republic of Korea., Bowles DW; Department of Medicine-Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Wong DJ; Department of Head and Neck Medical Oncology, University of California, Los Angeles (UCLA), Los Angeles, California., Ho AL; Department of Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Worden F; Rogel Cancer Center, Michigan Medicine at the University of Michigan, Ann Arbor, Michigan., Yun T; National Cancer Center, Goyang, Republic of Korea., Meng X; Elevar Therapeutics, Fort Lee, New Jersey., Van Tornout JM; Elevar Therapeutics, Fort Lee, New Jersey., Conlan MG; Elevar Therapeutics, Fort Lee, New Jersey., Kang H; Department of Oncology University of California, San Francisco (UCSF), San Francisco, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 14; Vol. 29 (22), pp. 4555-4563.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/adverse effects , Carcinoma, Adenoid Cystic*/drug therapy , Carcinoma, Adenoid Cystic*/pathology, Humans ; Vascular Endothelial Growth Factor A ; Vascular Endothelial Growth Factor Receptor-2 ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology

المؤلفون: Noel MS; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA., Kim S; TYME Technologies Inc., Bedminster, New Jersey, USA., Hartley ML; The Ruesch Center for the Cure of Gastrointestinal Cancers, Washington, District of Columbia, USA., Wong S; Sarcoma Oncology Research Center, Santa Monica, California, USA., Picozzi VJ; Virginia Mason Hospital and Medical Center, Seattle, Washington, USA., Staszewski H; Mather Hospital, Port Jefferson, New York, USA., Kim DW; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Van Tornout JM; TYME Technologies Inc., Bedminster, New Jersey, USA., Philip PA; Karmanos Cancer Center, Wayne State University, Michigan, Detroit, USA.; SWOG, Farmington Hills, Michigan, USA., Chung V; City of Hope, Duarte, California, USA., Ocean AJ; Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York, USA., Wang-Gillam A; Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.

المصدر: Cancer medicine [Cancer Med] 2022 Nov; Vol. 11 (22), pp. 4169-4181. Date of Electronic Publication: 2022 May 02.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/pathology , Adenocarcinoma*/pathology, Humans ; Methoxsalen/therapeutic use ; Phenytoin/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Sirolimus/adverse effects ; Quality of Life ; Pancreatic Neoplasms

المؤلفون: Mateo J; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK., Olmos D; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK.; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain., Dumez H; Department of Oncology, University Hospitals Leuven and KU Leuven, Leuven B-3000, Belgium., Poondru S; Astellas Pharma Global Development, Northbrook, IL 60201, USA., Samberg NL; Astellas Pharma Global Development, Northbrook, IL 60201, USA., Barr S; Astellas Pharma Global Development, Northbrook, IL 60201, USA., Van Tornout JM; Astellas Pharma Global Development, Northbrook, IL 60201, USA., Jie F; Astellas Pharma Global Development, Northbrook, IL 60201, USA., Sandhu S; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK., Tan DS; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK., Moreno V; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK., LoRusso PM; Yale University, New Haven, CT 06520, USA., Kaye SB; Drug Development Unit; The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London SM2 5PT, UK., Schöffski P; Department of Oncology, University Hospitals Leuven and KU Leuven, Leuven B-3000, Belgium.

المصدر: British journal of cancer [Br J Cancer] 2016 Apr 12; Vol. 114 (8), pp. 889-96. Date of Electronic Publication: 2016 Mar 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Imidazoles/*therapeutic use , Multiprotein Complexes/*antagonists & inhibitors , Neoplasms/*drug therapy , Protein Kinase Inhibitors/*therapeutic use , TOR Serine-Threonine Kinases/*antagonists & inhibitors , Triazines/*therapeutic use, Adult ; Aged ; Dose-Response Relationship, Drug ; Female ; Half-Life ; Humans ; Imidazoles/pharmacokinetics ; Leukocytes, Mononuclear/drug effects ; Male ; Maximum Tolerated Dose ; Mechanistic Target of Rapamycin Complex 1 ; Mechanistic Target of Rapamycin Complex 2 ; Middle Aged ; Neoplasms/pathology ; Protein Kinase Inhibitors/pharmacokinetics ; Triazines/pharmacokinetics ; Young Adult

المؤلفون: Cortes J; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA. jcortes@mdanderson.org, Kim DW, Raffoux E, Martinelli G, Ritchie E, Roy L, Coutre S, Corm S, Hamerschlak N, Tang JL, Hochhaus A, Khoury HJ, Brümmendorf TH, Michallet M, Rege-Cambrin G, Gambacorti-Passerini C, Radich JP, Ernst T, Zhu C, Van Tornout JM, Talpaz M

المصدر: Leukemia [Leukemia] 2008 Dec; Vol. 22 (12), pp. 2176-83. Date of Electronic Publication: 2008 Aug 28.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Blast Crisis/*drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*pathology , Protein Kinase Inhibitors/*administration & dosage , Pyrimidines/*administration & dosage , Thiazoles/*administration & dosage, Administration, Oral ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents ; Benzamides ; Combined Modality Therapy ; Dasatinib ; Disease-Free Survival ; Drug Resistance, Neoplasm ; Female ; Genes, abl/genetics ; Hematopoietic Stem Cell Transplantation ; Humans ; Imatinib Mesylate ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics ; Male ; Middle Aged ; Piperazines ; Protein Kinase Inhibitors/adverse effects ; Pyrimidines/adverse effects ; Thiazoles/adverse effects ; Treatment Outcome ; Young Adult

المؤلفون: Sainz J; Department of Radiology, Childrens Hospital Los Angeles, California 90027, USA., Van Tornout JM, Sayre J, Kaufman F, Gilsanz V

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 1999 Mar; Vol. 84 (3), pp. 853-5.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Print ISSN: 0021-972X (Print) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density/*physiology , Collagen/*genetics , Polymorphism, Genetic/*physiology, Aging/physiology ; Anthropometry ; Child ; Child Development/physiology ; Female ; Genotype ; Humans ; Lumbar Vertebrae/diagnostic imaging ; Lumbar Vertebrae/physiology ; Tomography, X-Ray Computed

المؤلفون: Sainz J; Department of Radiology, Children's Hospital of Los Angeles, CA 90027, USA., Van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V

المصدر: The New England journal of medicine [N Engl J Med] 1997 Jul 10; Vol. 337 (2), pp. 77-82.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Print ISSN: 0028-4793 (Print) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Bone Density/*genetics , Mexican Americans/*genetics , Receptors, Calcitriol/*genetics, Alleles ; Child ; Female ; Femur/physiology ; Genotype ; Humans ; Polymorphism, Genetic ; Spine/physiology ; Tomography, X-Ray Computed

المؤلفون: Van Tornout JM; Department of Pediatrics, JSC/Norris Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles 90033-0800, USA. vantorno@hsc.usc.edu, Spruck CH 3rd, Shibata A, Schmutte C, Gonzalez-Zulueta M, Nichols PW, Chandrasoma PT, Yu MC, Jones PA

المصدر: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 1997 Jul; Vol. 6 (7), pp. 493-7.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print Cited Medium: Print ISSN: 1055-9965 (Print) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Ethnicity/*statistics & numerical data , Nasopharyngeal Neoplasms/*epidemiology , Tumor Suppressor Protein p53/*genetics , Urban Population/*statistics & numerical data, Adolescent ; Adult ; Aged ; Causality ; DNA Mutational Analysis ; Ethnicity/genetics ; Female ; Humans ; Los Angeles/epidemiology ; Male ; Middle Aged ; Nasopharyngeal Neoplasms/genetics ; Risk